In this study, we evaluate whether patient-derived ECFCs demonstrate their own reservoir of MPO that may contribute to mitochondrially-associated endothelial dysfunction and CAD in a unique CTCA-characterised cohort and biobank. This evidence concerns the gene MPO and endothelial dysfunction.